Paul, Weiss
Chelsea Darnell
- Deals
- 6
- Latest
- Sep 2026
- Most deals in
- Food & Beverage
Firm
- Paul, Weiss Law firm · 2026 · 6 deals
Often works with
- Audrey Paquet 6 deals together
- Matthew Friestedt 5 deals together
- James Langston 4 deals together
- Matthew Leist 4 deals together
- Timothy Cruickshank 4 deals together
- Robert Holo 4 deals together
- Brian Krause 4 deals together
- Alyssa Wolpin 4 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Sep 2026 | 1.5-million-square-foot manufacturing and warehouse campus in Allentown, Pennsylvania | Keurig Dr Pepper | Chobani | Asset sale | Legal adviser to Keurig Dr Pepper (seller) | Announced | 125.0 | Food & Beverage+2 | Chobani acquisition of 1.5-million-square-foot manufacturing and warehouse campus in Allentown, Pennsylvania |
| Sep 2026 | Chobani | Keurig Dr Pepper | Chobani | Buy-back | Legal adviser to Keurig Dr Pepper (seller) | Announced | 800.0 | Dairy | Chobani share buy-back |
| Jun 2026 | Sangamo Therapeutics capsid delivery, zinc finger, modular integrase platforms and prion disease program | Sangamo Therapeutics | Eli Lilly and Company | Asset sale | Legal adviser to Eli Lilly and Company (acquirer) | Completed | – | Biotech+1 | Eli Lilly and Company acquisition of Sangamo Therapeutics capsid delivery, zinc finger, modular integrase platforms and prion disease program |
| Feb 2026 | beverage and coffee businesses | Keurig Dr Pepper | – | Demerger | Legal adviser to Keurig Dr Pepper (seller) | Announced | – | Beverages+1 | beverage and coffee businesses demerger |
| Feb 2026 | JDE Peet's | – | Keurig Dr Pepper | Acquisition | Legal adviser to Keurig Dr Pepper (acquirer) | Completed | 18,378.0 | Coffee | Keurig Dr Pepper acquisition of JDE Peet's |
| Feb 2026 | Orna Therapeutics | – | Eli Lilly and Company | Acquisition | Legal adviser to Eli Lilly and Company (acquirer) | Announced | 2,400.0 | Biotech+1 | Eli Lilly and Company acquisition of Orna Therapeutics |
Deals where Chelsea Darnell is named on the firm's deal team, by the firm or the press.